People with a body mass index (BMI) of greater than 30, or a BMI of 27 or more plus a weight-related health issue such as type 2 diabetes, high blood pressure or high cholesterol
How GLP-1 Transformed This Patients Life: Laura struggled with low energy and her relationship with food, but with The GLP-1 treatment, she gained confidence, increased energy, and a healthier outlook on life
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management
By comorbidity, including CKD, incident rates for hyperkalemia per 100 person years was 5.43 for people with type 2 diabetes, 8.7 for heart failure, 4.03 for people taking an ACEi or ARB, and 7.66 taking a steroidal MRA [21]
Oral semaglutide (Novo Nordisk): GLP-1 only
Kristen Fischer is a contributing writer at AARP based at the Jersey Shore